INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 416m ago
HOUSE PTR15m ago
SEC 13F15m ago
ROBINHOOD CHAIN15m ago
Public company

IDEXX Laboratories Inc

IDXXCIK 0000874716

EDGAR filingsOpen in network
Price$676.04
1 year-6.1%
Disclosed transactions0
Buys / sells0 / 0
Max Insider Score—
Connections with evidence6

IDXX · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2835 · In Vitro & In Vivo Diagnostic Substances · Nov 6, 2026
  • ← Insider ofevidence
    MICHAEL J LANEOfficer · Form 144 · Nov 3, 2026
  • ← Insider ofevidence
    JUNIUS DANIEL MDirector · Form 144 · Nov 3, 2026
  • ← Insider ofevidence
    SHARON E UNDERBERGOfficer · Form 144 · Nov 3, 2026
  • ← Insider ofevidence
JONATHAN J MAZELSKY
Officer, Director · Form 144 · Nov 3, 2026
  • ← Holds over 5% ofevidence
    Vanguard Portfolio Management5.04% of class · Schedule 13G · Oct 29, 2026

    • Planned sales and 5% stakes

    Form 144, 13D and 13G
    • JMJUNIUS DANIEL MDirector · sale around Nov 4, 2026 · 1,200 shares$840KForm 144 amendment · filed Nov 5, 2026
    • MLMICHAEL J LANEOfficer · sale around Nov 4, 2026 · 3,979 shares$2.74MForm 144 · filed Nov 4, 2026
    • SUSHARON E UNDERBERGOfficer · sale around Nov 4, 2026 · 8,906 shares$6.13MForm 144 · filed Nov 4, 2026
    • JMJONATHAN J MAZELSKYOfficer, Director · sale around Nov 4, 2026 · 25.1K shares$17.68MForm 144 · filed Nov 4, 2026
    • JMJUNIUS DANIEL MDirector · sale around Nov 4, 2026 · 500 shares$346KForm 144 · filed Nov 4, 2026
    • VMVanguard Portfolio ManagementPassive holder · crossed on Sep 30, 2026 · 3.97M shares5.04% of class13G · filed Oct 30, 2026